Evidence map›Paper›PMID 34578375›Full record

ArticleViruses2021

Characterization of Prion Disease Associated with a Two-Octapeptide Repeat Insertion.

Nicholas Brennecke, Ignazio Cali, Tze How Mok, Helen Speedy, Genomics England Research Consortium, Laszlo L P Hosszu, Christiane Stehmann, Laura Cracco, Gianfranco Puoti, Thomas W Prior and 4 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Genetic aspects of human prion diseases.Frontiers in neurology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Nicholas BrenneckeDepartment of Neurology, Case Western Reserve University & University Hospitals Cleveland Medical, Cleveland, OH 44106, USA.ORCID 0000-0003-1099-3440
Ignazio CaliDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Tze How MokMRC Prion Unit at University College London, Institute of Prion Diseases, London W1W 7FF, UK.
Helen SpeedyMRC Prion Unit at University College London, Institute of Prion Diseases, London W1W 7FF, UK.
Genomics England Research ConsortiumGenomics England Limited of Dawson Hall, Charterhouse Square, London EC1M 6BQ, UK.
Laszlo L P HosszuMRC Prion Unit at University College London, Institute of Prion Diseases, London W1W 7FF, UK.
Christiane StehmannAustralian National Creutzfeldt-Jakob Disease Registry, The Florey Institute, The University of Melbourne, Melbourne, VIC 3010, Australia.ORCID 0000-0001-8282-9151
Laura CraccoDepartment of Pathology and Laboratory Medicine, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
Gianfranco PuotiDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
Thomas W PriorCenter for Human Genetics Laboratory, Case Western Reserve University & University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
Mark L CohenDepartment of Neurology, Case Western Reserve University & University Hospitals Cleveland Medical, Cleveland, OH 44106, USA.
Steven J CollinsAustralian National Creutzfeldt-Jakob Disease Registry, The Florey Institute, The University of Melbourne, Melbourne, VIC 3010, Australia.
Simon MeadMRC Prion Unit at University College London, Institute of Prion Diseases, London W1W 7FF, UK.ORCID 0000-0002-4326-1468
Brian S ApplebyDepartment of Neurology, Case Western Reserve University & University Hospitals Cleveland Medical, Cleveland, OH 44106, USA.ORCID 0000-0003-2275-3292
MRC Prion Unit · GBUniversity Hospitals of Cleveland · USThe University of Melbourne · AUCase Western Reserve University · USIndiana University Indianapolis · USUniversity of Campania "Luigi Vanvitelli" · IT

Funding

Translational Therapeutics CoreP30AG062428 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI LEVERENZ, JAMES BRUCE · 2019 to 2020
$5.0M
Conformational properties of misfolded protein aggregates in cases involving the co-occurrence of prion disease and Alzehimer's disease or prion disease and CTEK99AG068359 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI CALI, IGNAZIO · 2020 to 2021
$242k
CDC HHS 1NU38CK000480Medical Research Council MC_UU_00024/1Medical Research Council MC_UU_00024/6NIA NIH HHS K99 AG068359NIA NIH HHS P30 AG062428NIH HHS AG068359Wellcome Trust
6 · The paper itself

Abstract

Genetic prion disease accounts for 10-15% of prion disease. While insertion of four or more octapeptide repeats are clearly pathogenic, smaller repeat insertions have an unclear pathogenicity. The goal of this case series was to provide an insight into the characteristics of the 2-octapeptide repeat genetic variant and to provide insight into the risk for Creutzfeldt-Jakob disease in asymptomatic carriers. 2-octapeptide repeat insertion prion disease cases were collected from the National Prion Disease Pathology Surveillance Center (US), the National Prion Clinic (UK), and the National Creutzfeldt-Jakob Disease Registry (Australia). Three largescale population genetic databases were queried for the 2-octapeptide repeat insertion allele. Eight cases of 2-octapeptide repeat insertion were identified. The cases were indistinguishable from the sporadic Creutzfeldt-Jakob cases of the same molecular subtype. Western blot characterization of the prion protein in the absence of enzymatic digestion with proteinase K revealed that 2-octapeptide repeat insertion and sporadic Creutzfeldt-Jakob disease have distinct prion protein profiles. Interrogation of large-scale population datasets suggested the variant is of very low penetrance. The 2-octapeptide repeat insertion is at most a low-risk genetic variant. Predictive genetic testing for asymptomatic blood relatives is not likely to be justified given the low risk.

Indexed as

AllelesMutagenesis, InsertionalAgedAged, 80 and overBrainCreutzfeldt-Jakob SyndromeFemaleHumansMaleMethionineMiddle AgedOligopeptidesPrion DiseasesPrion ProteinsPrionsMethionineOligopeptidesPrion ProteinsPrionsCreutzfeldt-Jakob diseasegenetic Creutzfeldt-Jakob diseasegeneticsoctapeptide repeat insertionprion disease

Identifiers

PMID34578375
PMCPMC8473248
OpenAlexW3196369914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.